Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shuhei Imoto
CMCdG, a Novel Nucleoside Analog, Exerts Potent Activity Against Wild-Type and Entecavir-Resistant HBV With Favorable Safety Feature
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
Novel HIV1 Non-Nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines With High Potency Against Wild-Type and Rilpivirine-Resistant E138K Mutant Virus
Renal Safety of Tenofovir and/or Entecavir in Patients With Chronic HBV Monoinfection
Therapeutics and Clinical Risk Management
The Anti-erbB3 Antibody MM-121/SAR256212 in Combination With Trastuzumab Exerts Potent Antitumor Activity Against Trastuzumab-Resistant Breast Cancer Cells
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-resistant Melanomas
Molecular Cancer Therapeutics
Cancer Research
Oncology
ACHN-490, a Neoglycoside With Potent in Vitro Activity Against Multidrug-Resistant Klebsiella Pneumoniae Isolates
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
A Novel Chimeric Endolysin With Antibacterial Activity Against Methicillin-Resistant Staphylococcus Aureus
Frontiers in Cellular and Infection Microbiology
Medicine
Infectious Diseases
Immunology
Microbiology
A Novel Ketolide, RBx 14255, With Activity Against Multidrug-Resistant Streptococcus Pneumoniae
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Clofarabine, a Novel Nucleoside Analog, Is Active in Pediatric Patients With Advanced Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Manadomanzamines a and B: A Novel Alkaloid Ring System With Potent Activity Against Mycobacteria and HIV-1.
ChemInform
